Consensus conference on chronic viral hepatitis and HIV infection: updated Spanish recommendations.
Chronic hepatitis B and C represent a leading cause of morbidity and mortality among human immunodeficiency virus (HIV)-infected patients worldwide. New treatment options against both hepatitis B (HBV) and C (HCV) viruses have prompted us to update previous recommendations for the management of coinfected individuals. Fifteen topics (nine related to HCV, five to HBV and one to both viruses) were selected for this purpose. A panel of Spanish experts in the field was invited to review these areas and propose specific recommendations, which were scored according to the Infectious Disease Society of America (IDSA) grading system. These guidelines represent a comprehensive and updated overview on the management of hepatitis B and C in HIV-infected patients.
Soriano
V
V
Service of Infectious Diseases, Hospital Carlos III, Madrid, Spain. vsoriano@dragonet.es
Miró
J M
JM
García-Samaniego
J
J
Torre-Cisneros
J
J
Núñez
M
M
del Romero
J
J
Martín-Carbonero
L
L
Castilla
J
J
Iribarren
J A
JA
Quereda
C
C
Santín
M
M
González
J
J
Arribas
J R
JR
Santos
I
I
Hernández-Quero
J
J
Ortega
E
E
Asensi
V
V
del Pozo
M A
MA
Berenguer
J
J
Tural
C
C
Clotet
B
B
Leal
M
M
Mallolas
J
J
Sánchez-Tapias
J M
JM
Moreno
S
S
Gatell
J M
JM
Téllez
M J
MJ
Rubio
R
R
Ledesma
E
E
Domingo
P
P
Barreiro
P
P
Pedreira
J
J
Romero
M
M
González-Lahoz
J
J
Lissen
E
E
D019380:Anti-HIV Agents / Q000009:adverse effects / Q000627:therapeutic use / Q000633:toxicity; D000998:Antiviral Agents / Q000009:adverse effects / Q000627:therapeutic use / Q000633:toxicity; D018450:Disease Progression; D018562:Disease Transmission, Infectious; D015658:HIV Infections / Q000150:complications*; D006514:Hepatitis B Surface Antigens / Q000097:blood; D019694:Hepatitis B, Chronic / Q000150:complications* / Q000503:physiopathology / Q000628:therapy*; D018937:Hepatitis C Antibodies / Q000097:blood; D019698:Hepatitis C, Chronic / Q000150:complications* / Q000503:physiopathology / Q000628:therapy*; D006801:Humans; D016031:Liver Transplantation; D014766:Viremia
D019380:Anti-HIV Agents; D000998:Antiviral Agents; D006514:Hepatitis B Surface Antigens; D018937:Hepatitis C Antibodies